Cipla launches inhalable insulin for diabetes care
New Delhi, Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central…
Lilly launches Mounjaro KwikPen in India
Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…
Biocon Bets Big on Insulin, Eyes GLP-1 Drugs for Future Growth
Bengaluru – Biocon Biologics, the biopharmaceutical arm of Biocon Ltd, is strengthening its foothold in the global insulin market while making a decisive move into the booming GLP-1 drug segment.…









